We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » University of Texas Restarts Halted Celebrex Trial
University of Texas Restarts Halted Celebrex Trial
July 7, 2005
A prominent cancer research institution has decided after a lengthy evaluation process to restart a clinical trial measuring the effects of Pfizer’s Celebrex against lung cancer.